| Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer. | |
| | |
MedLine Citation:
|
PMID: 21394046 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Over the past few years, several studies have proved the potential role of diagnostic procedures in patients with treated prostate cancer who develop biochemical relapse. Notably, no precise indications exist regarding the use of emerging modalities such as positron emission tomography/computerized tomography (PET/CT) scanning with radiolabeled choline. However, the literature suggests that the main and most important application of choline PET/CT at present is in disease restaging in cases of biochemical relapse for the detection of local, lymph node-related or distant recurrence. In this setting, it is well known that prostate-specific antigen (PSA) values play a significant role in the follow-up of these patients. This short review aims at summarizing the results of the most relevant published studies with particular interest directed towards a better understanding of the relationship between PSA kinetics and choline PET/CT detection rate and the potential use of PSA kinetics for an optimal selection of patients who may benefit most from this diagnostic procedure particularly at an early stage of biochemical recurrence. |
| | |
Authors:
|
Paolo Castellucci; Chiara Fuccio; Maria Cristina Marzola; Adil Al-Nahhas; Domenico Rubello; Stefano Fanti |
Related Documents
:
|
21915546 - Intervertebral disc health preservation after six months of spinal growth modulation. 16177436 - Contrast-enhanced mr angiography of subclavian steal syndrome: value of the 2d time-of-... 22357886 - Development of an intrabiliary mr imaging-monitored local agent delivery technique: a f... 18832666 - The jugular foramen: imaging strategy and detailed anatomy at 3t. 15831426 - Design, analysis and simulation for development of the first clinical micro-ct scanner. 8786866 - Somatostatin receptor scintigraphy in the differential diagnosis of meningioma. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-9 |
Journal Detail:
|
Title: Nuclear medicine communications Volume: - ISSN: 1473-5628 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8201017 Medline TA: Nucl Med Commun Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
aDepartment of Nuclear Medicine, Hematology-Oncology and Laboratory Medicine, Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant' Orsola-Malpighi, University of Bologna bDepartment of Nuclear Medicine, Medical Physics and Radiology, Santa Maria della Misericordia Hospital, Rovigo, Italy cDepartment of Nuclear Medicine, Hammersmith Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: What are the True Costs of Major Trauma?
Next Document: Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for del...